Even at Low Levels, Arsenic in Drinking Water Could Raise Heart Risks
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Oct. 23, 2024 -- Long-term exposure to even low levels of arsenic in drinking water can raise a person’s risk of heart disease, a new study warns.
Even folks exposed to arsenic levels below the federal limit of 10 micrograms per liter (ug/L) had an increased risk of heart disease, researchers reported Oct. 23 in the journal Environmental Health Perspectives.
“Our results are novel and encourage a renewed discussion of current policy and regulatory standards,” said senior researcher Tiffany Sanchez, an adjunct assistant professor of environmental health sciences with Columbia University’s Mailman School of Public Health in New York City.
“However, this also implies that much more research is needed to understand the risks associated with arsenic levels” in community drinking water, Sanchez added in a university news release.
The American Heart Association and leading health agencies agree there is substantial evidence that arsenic exposure increases the risk of heart problems.
The U.S. Environmental Protection Agency reduced the maximum contaminant level for arsenic in drinking water from 50 ug/L to 10 ug/L in 2006, but concerns remain that any level of exposure is unhealthy, researchers explained.
Arsenic naturally occurs in groundwater, and it's most commonly observed in regions of New England, the upper Midwest and the West, including California, researchers noted.
For this study, researchers tracked health data from a long-term study of more than 98,000 California teachers, comparing cases of heart disease with exposure to arsenic in drinking water.
Nearly half (48%) of the participants were exposed to an average arsenic concentration below California’s public health goal of less than 1 ug/L, researchers said.
Those exposed to an average 1 to 5 ug/L of arsenic in drinking water had a 5% to 6% increased risk of heart disease.
Heart disease risk jumped to 20% among those in the exposure range of 5 to 10 ug/L, which is below the current federal limit, researchers said.
The risk then doubled to 42% for those exposed to levels at or above the current EPA limit of 10 ug/L, results show.
“Our findings shed light on critical time windows of arsenic exposure that contribute to heart disease and inform the ongoing arsenic risk assessment by the EPA. It further reinforces the importance of considering non-cancer outcomes, and specifically cardiovascular disease, which is the number one cause of death in the U.S. and globally,” said researcher Danielle Medgyesi, a doctoral fellow of environmental health sciences at Columbia. “This study offers resounding proof of the need for regulatory standards in protecting health and provides evidence in support of reducing the current limit to further eliminate significant risk.”
Sources
- Columbia University, news release, Oct. 23, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Tens Of Thousands of Heart Attacks, Strokes Could Be Prevented With Cholesterol Lowering Medications
WEDNESDAY, July 2, 2025 — Tens of thousands of people suffer needless heart attacks and strokes every year because they aren’t taking cholesterol-lowering drugs, a new...
Nestle, Other Food Companies Vow to Ban Artificial Colors
MONDAY, June 30, 2025 — Nestle has joined a growing list of major food companies pledging to voluntarily eliminate artificial colors from their U.S. products by the middle...
Toxic Mercury in Gators Is a Warning Sign for Other Species
SUNDAY, June 29, 2025 — The swamps of Georgia and South Carolina harbor something more dangerous than the alligators for which they’re best known. Researchers...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.